Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06673290 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Different Doses of Sirolimus for the Treatment of Cystic Lymphatic Malformations

StatusRecruiting
PhasePhase 2/3
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Site contact updated
    • Publications: details revised at 8 of 8 entries
    • Study description expanded, about 1 word
    v3
  2. Re-verified, no change to tracked fieldsv2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this study is to compare the efficacy and safety of different concentration gradients of sirolimus in the treatment of cystic lymphatic malformation.
Trial Details
NCT Number NCT06673290
Lead Sponsor West China Hospital
Conditions
(from sponsor)		 Lymphatic Malformation
Related terms Lymphatic Abnormalities
Enrollment 150 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov